Guidant

Total investments

10

Average round size

13M

Portfolio companies

8

Rounds per year

0.37

Lead investments

1

Follow on index

0.20

Exits

5

Areas of investment
Therapeutic DevicesSurgical DevicesBiotechnologyHealth CareManufacturingMedical DeviceMedicalDeveloper PlatformPharmaceuticalTherapeutics

Summary

Guidant is the famous Corporate Investor, which was founded in 1994. The main office of represented Corporate Investor is situated in the Indianapolis. The venture was found in North America in United States.

The important activity for fund was in 2004. Deals in the range of 10 - 50 millions dollars are the general things for fund. The typical startup value when the investment from Guidant is 100-500 millions dollars. Speaking about the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. This Guidant works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2008.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Guidant, startups are often financed by Sanderling Ventures, Biofrontier Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, Sanderling Ventures, Oxford Bioscience Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Versant Ventures, Three Arch Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Intrapace, Bioheart, CardioMEMS.

Show more

Investments analytics

Analytics

Total investments
10
Lead investments
1
Exits
5
Rounds per year
0.37
Follow on index
0.20
Investments by industry
  • Health Care (10)
  • Medical Device (8)
  • Biotechnology (6)
  • Medical (3)
  • Pharmaceutical (3)
  • Show 6 more
Investments by region
  • United States (9)
  • Israel (1)
Peak activity year
2004

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
23
Avg. valuation at time of investment
143M
Group Appearance index
0.90
Avg. company exit year
11
Avg. multiplicator
2.28

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Intrapace 14 Jul 2004 Biotechnology, Health Care, Health Diagnostics Late Stage Venture 14M United States, California, San Jose
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.